BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Yamanouchi Pharma America, Inc. 

S. 61 Paramus Road
Mack Centre IV, 4th Floor
Paramus  New Jersey  07652  U.S.A.
Phone: 201-291-2556 Fax: 201-909-3002


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Yamanouchi Pharmaceutical Co., Ltd. And Fujisawa Pharmaceutical Co., Ltd. Unite To Form Astellas Pharma Inc., North American Headquarters To Be In Chicago 10/19/2005 5:13:11 PM    More...
FDA Issues Approvable Letter For Yamanouchi Pharma America, Inc.'s Investigational Hyponatremia Treatment Conivaptan Hydrochloride Injection 10/19/2005 5:12:19 PM    More...
GlaxoSmithKline (GSK) And Yamanouchi Pharmaceutical Co., Ltd. Release: FDA Approves Vesicare(R) (Solifenacin Succinate) For The Treatment Of Overactive Bladder 10/19/2005 5:12:15 PM    More...
Yamanouchi Pharma America, Inc. Release: New Data From Two Studies Support Efficacy And Tolerability Of Vasopressin Receptor Antagonist Conivaptan Hydrochloride In Patients With Hyponatremia 10/19/2005 5:12:01 PM    More...
GlaxoSmithKline (GSK) And Yamanouchi Pharmaceutical Co., Ltd. Release: New Data Show Once-Daily Solifenacin Succinate Significantly Reduced Urgency Episodes For Patients With Overactive Bladder 10/19/2005 5:11:21 PM    More...
GlaxoSmithKline (GSK) And Yamanouchi Pharmaceutical Co., Ltd. Release: Once-Daily Solifenacin Succinate Improved Key Symptoms of Overactive Bladder In Women 10/19/2005 5:11:11 PM    More...
Astellas Pharma Inc. Release: Anti-Fungal Agent MYCAMINE(TM) Available To Physicians 10/19/2005 5:10:11 PM    More...
Yamanouchi Pharma America, Inc. Submits New Drug Application To The FDA For Conivaptan Hydrochloride To Treat Hyponatremia 10/19/2005 5:09:52 PM    More...
Yamanouchi Pharma America, Inc. Release: Study Shows Vasopressin Receptor Antagonist Conivaptan Hydrochloride Significantly Increased Serum Sodium Concentration In Patients With Hyponatremia 10/19/2005 5:08:42 PM    More...

//-->